Xu Y

ORCID: 0000-0001-8663-2452 · 244 papers in corpus
Frontiers in medicine
other 2026
Human mutation ·doi:10.1155/humu/9501547

BACKGROUND: Endometriosis (EM) is a chronic, estrogen-dependent disease that lacks reliable noninvasive diagnostic biomarkers. This study was aimed at evaluating the diagnostic value of PAX8 using integrated transcriptomic and machine learn…

observational 2026
Biomedicines ·doi:10.3390/biomedicines14040769

Background: Polycystic ovary syndrome (PCOS) is characterized by substantial inter-individual variability in ovarian sensitivity to recombinant follicle-stimulating hormone (rFSH) during controlled ovarian stimulation (COS). Clinically appl…

other 2026
Frontiers in oncology ·doi:10.3389/fonc.2026.1730276

BACKGROUND: Pelvic floor dysfunction (PFD) is a common functional disorder following total hysterectomy. Currently, the assessment mainly relies on manual measurements of transperineal ultrasound (TPUS) images, which suffers from low effici…

observational 2026
BMC psychology ·doi:10.1186/s40359-026-04235-9

BACKGROUND: Patients undergoing assisted reproductive technology (ART) frequently manifest sleep disturbances and psychological morbidity. This study examined associations between cerebral activation patterns, sleep quality, and psychologic…

lab-animal 2026
ACS nano ·doi:10.1021/acsnano.5c18417

Endometriosis is a common, estrogen-driven chronic gynecologic disorder defined by the ectopic growth of endometrial-like tissue within the peritoneal cavity. Existing treatment options, primarily surgery and hormonal therapy, are limited b…

other 2026
NPJ digital medicine ·doi:10.1038/s41746-025-02332-4

Digital symptom checkers (SCs) are increasingly used to support early symptom recognition and care-seeking, yet evidence on their cost-effectiveness remains limited. We conducted an economic evaluation of a digital SC for endometriosis, a p…

other 2026
Frontiers in medicine ·doi:10.3389/fmed.2026.1680327

OBJECTIVE: To evaluate the clinical efficacy of Xiaonang Yusi decoction (XNYSD, ) in patients with phlegm-dampness type polycystic ovary syndrome (PCOS) undergoing in vitro fertilization and embryo transfer (IVF-ET), and to investigate its …

other 2026
Medicine ·doi:10.1097/md.0000000000048454

This study aims to elucidate the molecular mechanisms underlying luteolin's therapeutic effects on polycystic ovary syndrome (PCOS) and endometriosis (EM), thereby providing a theoretical foundation for developing novel treatment strategies…

other 2026
La Radiologia medica ·doi:10.1007/s11547-025-02152-2

OBJECTIVES: To evaluate the feasibility of quantitative susceptibility mapping (QSM) and R2* mapping in assessing iron deposition in endometriotic ovarian cysts (EMO) and their potential implications for ovarian reserve. MATERIALS AND METH…

lab-animal 2026
Journal of ovarian research ·doi:10.1186/s13048-026-02193-9

Ovarian aging, marked by a progressive diminution of oocyte quality and quantity, is a major contributor to declining female fertility and age-related reproductive disorders. However, transcript-level changes underlying this process remain …

other 2026
Trials ·doi:10.1186/s13063-026-09731-2

BACKGROUND: Adenomyosis, an estrogen-dependent condition characterized by endometrial invasion into the myometrium, is associated with reduced live birth rates and increased miscarriage risk in women undergoing assisted reproductive technol…

observational 2026
Frontiers in cellular and infection microbiology ·doi:10.3389/fcimb.2026.1720894

BACKGROUND: The specific gut microbial signatures and their correlation with immune-inflammatory markers in infertile women with endometriosis remain underexplored.To investigate the differences in gut microbiota and their associations with…

review 2026
Frontiers in microbiology ·doi:10.3389/fmicb.2026.1822640

When exploring the macro trend of declining global fertility rates, a pathological factor often hidden beneath individual suffering cannot be ignored: pelvic inflammatory disease (PID). Recurrent inflammation leads to tissue damage, adhesio…

lab-animal 2026
Advanced science (Weinheim, Baden-Wurttemberg, Germany) ·doi:10.1002/advs.202520787

Despite ongoing challenges in developing effective non-surgical and non-hormonal treatments for endometriosis, the psychological manifestations of the disease-particularly anxiety-remain comparatively underexplored. In this study, a hydroge…

observational 2026
BMC musculoskeletal disorders ·doi:10.1186/s12891-026-09804-y

BACKGROUND: In clinical practice, we noticed that a large group of young female patients diagnosed with femoroacetabular impingement syndrome (FAIS) suffer from hip/groin pain in daily lives and particularly during menstruation. However, it…

nonrandomized-trial 2026
BMC women's health ·doi:10.1186/s12905-026-04438-7

BACKGROUND: Expulsion of the levonorgestrel-releasing intrauterine system (LNG-IUS) limits its effectiveness in adenomyosis management, particularly in patients with anatomical risk factors. This study aimed to assess the feasibility and sh…

other 2026
Scientific reports ·doi:10.1038/s41598-026-37277-5

Endometriosis is a chronic estrogen-dependent disorder affecting up to 10% of women of reproductive age, and the absence of reliable noninvasive diagnostic tools contributes to delayed diagnosis and disease progression. To identify potentia…

lab-animal 2026
Journal of biochemical and molecular toxicology ·doi:10.1002/jbt.70897

Endometriosis is an estrogen-dependent disorder characterized by ectopic growth of endometrial tissue. There is a lack of effective biomarkers for early detection and revealing mechanisms of endometriosis. CSNK2A1 is a compositionally activ…

other 2026
EBioMedicine ·doi:10.1016/j.ebiom.2026.106256

BACKGROUND: Cervical squamous cell carcinoma (CSCC) exhibits profound spatial heterogeneity in evolutionary trajectories across distinct tumour foci, yet the underlying mechanisms remain poorly understood. METHODS: In this study, we perfor…

other 2026
Computational biology and chemistry ·doi:10.1016/j.compbiolchem.2026.109349

BACKGROUND: Endometriosis affects approximately 10% of reproductive-age women, with a diagnostic delay of 7-10 years. Despite clinical heterogeneity, current rASRM staging poorly predicts treatment outcomes. Molecular subtyping may reveal b…

other 2026
Communications medicine ·doi:10.1038/s43856-026-01379-y

BACKGROUND: Ovarian cancer is a major female reproductive health issue with heterogeneous biological features on its subtypes, which may require different therapeutic strategies. Glucagon-like peptide-1 receptor (GLP-1R) agonists were repor…

lab-animal 2026
Cell death & disease ·doi:10.1038/s41419-026-08886-9

Metabolic determinants of oocyte quality and embryonic development remain incompletely understood. Here, we profiled metabolites in human cumulus cells (CCs) and follicular fluid (FF), validated in two mouse models, and integrated transcrip…

observational 2026
Journal of translational medicine ·doi:10.1186/s12967-026-08586-0

BACKGROUND: Intracytoplasmic sperm injection (ICSI) is performed in over half of assisted reproductive technology cycles globally; however, the optimal interval between oocyte denudation and sperm injection remains undefined in clinical gui…

observational 2026
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2026.2668866

OBJECTIVE: To compare the efficacy of different COH protocols on pregnancy outcomes in adenomyosis patients. STUDY DESIGN: A real-world retrospective cohort study analyzed 1486 IVF-ET cycles in adenomyosis patients who received COH regimen…